Thiazovivin is a selective inhibitor of Rho-associated coiled-coil containing protein kinase (ROCK), a serine/threonine kinase that plays a role in cell polarity, contraction, and actin cytoskeleton reorganization (Xu et al.) Thiazovivin is effective at 5-fold-lower concentrations than another common ROCK inhibitor Y-27632 (Catalog #72302; Xu et al.)
Promotes survival of human embryonic stem (ES) cells during dissociation by stabilizing E-cadherin and improves cell attachment (Xu et al.)
Promotes survival of single human induced pluripotent stem (iPS) cells during transfection for TALEN-mediated genome editing (Sun and Zhao)
Increases the efficiency of reprogramming human somatic cells to iPS cells, in combination with PD0325091 and SB431542 (Lin et al.)
Increases the efficiency of reprogramming human cord blood mononuclear cells to iPS cells (Hu et al.)
Caractéristiques techniques
Marque
STEMCELL Technologies
Réf. B-LABO
BL-RE-151742
Réf. fabricant
17129971
CAS
1226056-71-8
Synonyme
Tzv
Quantité
25 mg
Formule moléculaire
C<sub>15</sub>H<sub>13</sub>N<sub>5</sub>OS
Pureté
≥98%
Une question, une configuration particulière ? Contactez-nous pour un devis.
